Platform Technology Partners Gritstone Bio, Inc. Transaction History

Platform Technology Partners

  • $311 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021
SELL
$6.41 - $13.54 $70,189 - $148,263
-10,950 Closed
0 $0
Q2 2021

Aug 05, 2021
SELL
$8.13 - $10.2 $30,894 - $38,760
-3,800 Reduced 25.76%
10,950 $100,000
Q4 2020

Feb 09, 2021
BUY
$2.57 - $4.22 $37,907 - $62,244
14,750 New
14,750 $58,000

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Platform Technology Partners Portfolio

Follow Platform Technology Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email